Jimmy drafts and prosecutes patent applications relating to a broad range of inventions in the biotechnology and life sciences fields, spanning immunology, antibodies, antibody discovery, genetic engineering, nucleic acid amplification, biosensors, and food technology. He has a keen interest in genetics and protein biochemistry, having worked on isolating a protein complex involved in regulation of a tumour suppressor locus in his PhD studies.
Jimmy works with a variety of clients in Europe, the US and elsewhere including small to mid-size biotechnology companies, technology transfer offices and university spin-outs, handling patent portfolios covering many countries. He has developed patent portfolios from scratch for start-up companies and also assisted with due diligence exercises.
Jimmy additionally has experience with analysis of third party patents and portfolios, including global surveillance and pre/post-grant challenge of competitor patents and patent applications, and freedom to operate searches and opinions. He also has worked on multiple Oppositions and Appeals at the European Patent Office and has been involved in a multinational opposition/litigation project relating to transgenic animal platforms for antibody discovery.
Jimmy joined J A Kemp in 2006, qualified as a European patent attorney and UK Chartered Patent Attorney In 2010 and became a partner in 2016. He is responsible for monitoring developments in UK patent law for the firm. Jimmy is also a dual British/French national and speaks fluent French – he relocated to France in 2018 to join J A Kemp’s Paris office.
University of Oxford, Masters Degree in Biochemistry; Cancer Research UK and University College London, PhD in Molecular Biology
European Patent Attorney; UK Chartered Patent Attorney
Fellow of the Chartered Institute of Patent Attorneys (CIPA); Member of the Institute of Professional Representatives before the European Patent Office (EPI)